web analytics
1.7 C
Wednesday, November 30, 2022


metastatic Triple Negative Breast Cancer

CytoDyn’s Robust Platform Technology Keeps Expanding Into Breakthrough Therapy Designation Territory

Leronlimab is an immunomodulator that targets many diseases Multiple indications being pursued in parallel Proven safety profile, novel mechanism of action, & ease...

Latest news